Adage Capital Partners Gp, L.L.C. Harmony Biosciences Holdings, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

$54.6 Billion
Q3 2024

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 300,000 shares of HRMY stock, worth $10.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

300,000

Previous 50,000 500.0%

Holding current value

$10.2 Million

Previous $1.51 Million 694.76%

% of portfolio

0.02%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$30.0 - $39.95 $7.5 Million - $9.99 Million	250,000 Added 500.0%	300,000 $12 Million
Q2 2024 Aug 14, 2024	SELL	$28.81 - $33.01 $720,250 - $825,250	-25,000 Reduced 33.33%	50,000 $1.51 Million
Q1 2024 May 15, 2024	SELL	$29.93 - $35.06 $748,250 - $876,500	-25,000 Reduced 25.0%	75,000 $2.52 Million
Q4 2023 Feb 14, 2024	SELL	$19.2 - $33.78 $25.3 Million - $44.6 Million	-1,320,000 Reduced 92.96%	100,000 $3.23 Million
Q3 2023 Nov 14, 2023	BUY	$31.89 - $39.03 $7.02 Million - $8.59 Million	220,000 Added 18.33%	1,420,000 $46.5 Million
Q2 2023 Aug 14, 2023	SELL	$30.5 - $37.4 $6.56 Million - $8.04 Million	-215,000 Reduced 15.19%	1,200,000 $42.2 Million
Q1 2023 May 15, 2023	BUY	$30.8 - $53.92 $39.6 Million - $69.3 Million	1,285,000 Added 988.46%	1,415,000 $46.2 Million
Q4 2022 Feb 14, 2023	SELL	$45.4 - $60.91 $20.9 Million - $28 Million	-460,000 Reduced 77.97%	130,000 $7.16 Million
Q3 2022 Nov 14, 2022	SELL	$42.06 - $55.45 $18.7 Million - $24.6 Million	-444,450 Reduced 42.96%	590,000 $26.1 Million
Q2 2022 Aug 15, 2022	SELL	$33.54 - $52.15 $3.28 Million - $5.1 Million	-97,766 Reduced 8.63%	1,034,450 $50.5 Million
Q1 2022 May 16, 2022	SELL	$33.14 - $51.13 $20.5 Million - $31.6 Million	-617,784 Reduced 35.3%	1,132,216 $55.1 Million
Q4 2021 Feb 14, 2022	BUY	$34.09 - $43.91 $17.4 Million - $22.4 Million	509,585 Added 41.08%	1,750,000 $74.6 Million
Q3 2021 Nov 15, 2021	BUY	$25.68 - $38.61 $31.9 Million - $47.9 Million	1,240,415 New	1,240,415 $47.5 Million

Others Institutions Holding HRMY

# of Institutions

242

Shares Held

45.1M

Call Options Held

108K

Put Options Held

49.2K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.02B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Harmony Biosciences Holdings, Inc. Transaction History